4//SEC Filing
WORLAND STEPHEN T 4
Accession 0001209191-22-037681
CIK 0001394319other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 9:36 PM ET
Size
8.8 KB
Accession
0001209191-22-037681
Insider Transaction Report
Form 4
WORLAND STEPHEN T
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-06-14+15,750→ 15,750 totalExercise: $1.30Exp: 2032-06-13→ Common Stock (15,750 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan).
Issuer
Tracon Pharmaceuticals, Inc.
CIK 0001394319
Entity typeother
Related Parties
1- filerCIK 0001283307
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 9:36 PM ET
- Size
- 8.8 KB